Clade Therapeutics

Come and join biomodal at Clade Therapeutics

12:00 pm


1:30 pm,
29 September 2023
Clade Therapeutics/Landmark Center
401 Park Drive, Boston, MA 02215
United States of America

Talk details: Maximising your omic research: generating more information from limited amounts of DNA

Speaker: Mark Consugar, Lead Field Application Scientist at bimodal.

  • Preserve valuable samples: utilise samples as low as 10ng of DNA for highly accurate modC. 
  • C-to-T mutation detection: simultaneously detect the most common type of genetic mutation (C-to-T) in the human genome and cancer.  
  • Whole genome investigation: get simultaneous whole genome sequencing results with standard SNP detection and epigenetic marks with improved sensitivity and specificity.  
  • Allele-specific methylation: attain phased results for allele-specific methylation (ASM) and maintain even genomic coverage. 
  • Seamless bioinformatics integration: gain a fully optimised bioinformatics pipeline using existing alignment and SNP calling, plus a proprietary module for epigenetic and ASM quantification.
clade therapeutics 2023

Register your interest

Cambridge Epigenetix is now biomodal